AstraZeneca PLC confirmed it is considering the spin-off of Astra Tech business, Reuters reported. AstraZeneca hired JP Morgan Chase to help with the review of options for the dental implants and medical devices maker. A source familiar with the situation told Reuters earlier this week that the Anglo-Swedish drugmaker was looking to sell the Swedish-based business for $2 billion.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
